Heron Therapeutics Inc (NASDAQ:HRTX)

14.22
Delayed Data
As of Mar 27
 +0.23 / +1.64%
Today’s Change
6.51
Today|||52-Week Range
16.49
+41.35%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
AssetsCash--53.5M72.3M--
 
 
 
Short Term Investment Cash15.9M35.5M18.8M--
 
 
 
 
Cash & Short Term Investments18.0M53.5M72.3M72.7M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.00----
 
InventoriesInventories0.000.000.00----
 
Current AssetsOther Current Assets266.0K584.0K638.0K--
 
 
 
 
Current Assets18.2M54.1M72.9M--
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross5.4M6.2M7.2M--
 
 
 
 
Depreciation-4.3M-4.4M-4.3M--
 
 
 
 
Other Assets130.0K130.0K130.0K--
 
 
 
 
Total Assets19.4M56.0M75.9M76.7M
 
 
 
 
 
 
LiabilitiesAccounts Payable1.0M1.9M1.3M--
 
 
 
 
Short Term Debt103.0K492.0K1.0M--
 
 
 
 
Accrued Expenses2.0M1.3M2.1M--
 
 
 
 
Other Current Liabilities2.0M1.3M2.1M--
 
 
 
 
Other Liabilities3.7M4.2M7.0M--
 
 
 
 
 
Total LiabilitiesTotal Liabilities3.7M4.2M7.0M--
 
 
 
 
 
EquityMinority Interest0.000.000.00----
Preferred Stock0.000.000.00----
Common Equity15.8M51.8M68.9M63.1M
 
 
 
 
 
Total Shareholder Equity15.8M51.8M68.9M63.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding10.0M15.1M23.6M--
 
 
 
 
 
Addtl. Info.No data currently available for this section.
 

To view my watchlist

Not a member yet?

Sign up now for a free account